Little FDA oversight of Chinese, Indian drugs despite deaths

06/17/2007 | Washington Post, The · NYTimes.com

Cheaper drugs and ingredients from China and India are becoming an increasing part of U.S. sales of generics and over-the-counter drugs without FDA oversight. The agency rarely conducts quality-control inspections in the two countries, even after an ingredient in a Chinese drug caused dozens of deaths in Haiti a decade ago and again recently in Panama.

View Full Article in:

Washington Post, The · NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN